» Articles » PMID: 9708180

Th1 and Th2 Cell Involvement in Immune Response to Salmonella Typhimurium Porins

Overview
Journal Immunology
Date 1998 Aug 26
PMID 9708180
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

In understanding the regulation of the specific immune response to Salmonella typhimurium, the role of a surface major component (porins) was studied. In this study we demonstrate that purified porins are able to induce a different response to that induced by the porins present on the S. typhimurium cell surface. Porin-treated or orally infected mice show anti-porin antibodies with bactericidal activity. The complete adoptive transfer of resistance to S. typhimurium is achieved only using splenic T cells from survivor mice after experimental infection. After stimulation with specific antigen in vitro CD4+ cells from porin-immunized mice released large amounts of interleukin-4 (IL-4), at a time when CD4+ cells from S. typhimurium-infected mice predominantly secreted interferon-gamma (IFN-gamma). Limiting dilution analysis showed that infection resulted in a higher precursor frequency of IFN-gamma-producing CD4+ T cells and a lower precursor frequency of IL-4-producing CD4+ T cells, while immunization with porins resulted in a higher precursor frequency of IL-4-producing cells and a low frequency of IFN-gamma-producing cells. Analysis of polymerase chain reaction-amplified cDNA from the spleens of infected mice revealed that IFN-gamma, IL-2 and IL-12 p40 mRNA were found 5 days after in vitro challenge and increased after 15 days; IL-10 expression was barely present after both 5 and 15 days, while IL-4 mRNA expression was not detected. In immunized mice, the IL-4 mRNA expression increased after 15 days, IFN-gamma mRNA expression disappeared entirely after 15 days, while IL-2, IL-10 and IL-12 mRNA remained relatively unchanged.

Citing Articles

Assessment of microbiological correlates and immunostimulatory potential of electron beam inactivated metabolically active yet non culturable (MAyNC) Salmonella Typhimurium.

Praveen C, Bhatia S, Alaniz R, Droleskey R, Cohen N, Jesudhasan P PLoS One. 2021; 16(4):e0243417.

PMID: 33861743 PMC: 8051754. DOI: 10.1371/journal.pone.0243417.


Surface engineered polyanhydride-based oral subunit nanovaccine for poultry.

Renu S, Markazi A, Dhakal S, Lakshmanappa Y, Gourapura S, Shanmugasundaram R Int J Nanomedicine. 2018; 13:8195-8215.

PMID: 30555234 PMC: 6280892. DOI: 10.2147/IJN.S185588.


Peptides complementary to the active loop of porin P2 from Haemophilus influenzae modulate its activity.

Cantisani M, Vitiello M, Falanga A, Finamore E, Galdiero M, Galdiero S Int J Nanomedicine. 2012; 7:2361-71.

PMID: 22654515 PMC: 3363952. DOI: 10.2147/IJN.S30467.


An enteric pathogen Salmonella enterica serovar Typhimurium suppresses tumor growth by downregulating CD44high and CD4T regulatory (Treg) cell expression in mice: the critical role of lipopolysaccharide and Braun lipoprotein in modulating tumor....

Liu T, Chopra A Cancer Gene Ther. 2009; 17(2):97-108.

PMID: 19713997 PMC: 2808459. DOI: 10.1038/cgt.2009.58.


Oral vaccination with a recombinant Salmonella vaccine vector provokes systemic HIV-1 subtype C Gag-specific CD4+ Th1 and Th2 cell immune responses in mice.

Chinombe N, Bourn W, Williamson A, Shephard E Virol J. 2009; 6:87.

PMID: 19555490 PMC: 2708135. DOI: 10.1186/1743-422X-6-87.


References
1.
Rifkind D . Prevention by polymyxin B of endotoxin lethality in mice. J Bacteriol. 1967; 93(4):1463-4. PMC: 276625. DOI: 10.1128/jb.93.4.1463-1464.1967. View

2.
NAUCIEL C . Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection. Infect Immun. 1992; 60(2):450-4. PMC: 257648. DOI: 10.1128/iai.60.2.450-454.1992. View

3.
Munkley A, Tinsley C, Virji M, Heckels J . Blocking of bactericidal killing of Neisseria meningitidis by antibodies directed against class 4 outer membrane protein. Microb Pathog. 1991; 11(6):447-52. DOI: 10.1016/0882-4010(91)90041-8. View

4.
Matsui K, Arai T . The comparison of cell-mediated immunity induced by immunization with porin, viable cells and killed cells of Salmonella typhimurium. Microbiol Immunol. 1992; 36(3):269-78. DOI: 10.1111/j.1348-0421.1992.tb01664.x. View

5.
Wetzler L, Blake M, Barry K, Gotschlich E . Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants. J Infect Dis. 1992; 166(3):551-5. DOI: 10.1093/infdis/166.3.551. View